Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab

被引：2

作者：

Christensen, Britt ^{[1
]}

Rubin, David T. ^{[1
]}

Goeppinger, Sarah ^{[1
]}

Colman, Ruben J. ^{[1
]}

Yarur, Andres ^{[1
]}

Hirsch, Ayal ^{[1
]}

Bocheneck, Ashley ^{[1
]}

Wichmann, Alana ^{[1
]}

Sakuraba, Atsushi ^{[2
]}

Cohen, Russell ^{[1
]}

Siddiqui, Dania ^{[1
]}

机构：

[1] Univ Chicago Med, Chicago, IL USA

[2] Univ Chicago, Chicago, IL 60637 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷

关键词：

D O I：

10.14309/00000434-201510001-01843

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1843

引用

页码：S783 / S784

页数：2

共 50 条

[41] Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab
Hu, Anne
Kotze, Paulo Gustavo
Burgevin, Alice
Tan, Willam
Jess, Alison
Li, Pei-Shun
Kroeker, Karen
Halloran, Brendan
Panaccione, Remo
Peyrin-Biroulet, Laurent
Ma, Christopher
Ananthakrishnan, Ashwin N.
[J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1366 - +
[42] Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Shmidt, Eugenia
Kochhar, Gursimran
Hartke, Justin
Chilukuri, Prianka
Meserve, Joseph
Chaudrey, Khadija
Koliani-Pace, Jenna L.
Hirten, Robert
Faleck, David
Barocas, Morris
Luo, Michelle
Lasch, Karen
Boland, Brigid S.
Singh, Siddharth
Vande Casteele, Niels
Sagi, Sashidhar Varma
Fischer, Monika
Chang, Shannon
Bohm, Matthew
Lukin, Dana
Sultan, Keith
Swaminath, Arun
Hudesman, David
Gupta, Nitin
Kane, Sunanda
Loftus, Edward V., Jr.
Sandborn, William J.
Siegel, Corey A.
Sands, Bruce E.
Colombel, Jean-Frederic
Shen, Bo
Dulai, Parambir S.
[J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2461 - 2467
[43] RATES AND PREDICTORS OF SURGERY IN INFLAMMATORY BOWEL DISEASE PATIENTS INITIATING VEDOLIZUMAB THERAPY: RESULTS FROM THE VICTORY CONSORTIUM
Koliani-Pace, Jenna L.
Chaudrey, Khadija
Kochhar, Gursimran
Shmidt, Eugenia
Hartke, Justin G.
Chilukuri, Prianka
Parikh, Malav P.
Hirten, Robert
Meserve, Joseph D.
Luo, Michelle
Barocas, Morris
Lasch, Karen
Singh, Siddharth
Boland, Brigid S.
Sultan, Keith
Swaminath, Arun
Bohm, Matthew
Lukin, Dana J.
Hudesman, David
Sands, Bruce E.
Colombel, Jean Frederic
Sandborn, William J.
Shen, Bo
Kane, Sunanda V.
Siegel, Corey A.
Loftus, Edward V.
Dulai, Parambir
[J]. GASTROENTEROLOGY, 2017, 152 (05) : S779 - S779
[44] Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide Study
Marild, Karl
Soderling, Jonas
Stephansson, Olof
Axelrad, Jordan
Halfvarson, Jonas
Broms, Gabriella
Marsal, Jan
Olen, Ola
Ludvigsson, Jonas F.
[J]. GASTROENTEROLOGY, 2024, 166 (05)
[45] Inflammatory bowel disease patients with PSC frequently have subclinical endoscopic and histologic activity
Cleveland, N. Krugliak
Rubin, D.
Meckel, K.
Tran, A.
Gonsalves, A.
Gaetano, J.
Williams, K.
Jabri, B.
Pekow, J.
[J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S226 - S226
[46] Care of inflammatory bowel disease patients in remission
Subramanian, Charumathi Raghu
Triadafilopoulos, George
[J]. GASTROENTEROLOGY REPORT, 2016, 4 (04): : 261 - 271
[47] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Haddley, K.
[J]. DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
[48] Vedolizumab (Entyvio) for Inflammatory Bowel Disease
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 86 - 88
[49] Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) Patients During Maintenance Therapy
Ungaro, Ryan
Jossen, Jacqueline
Phan, Becky
Chefitz, Ezra
Jain, Anjali
Naik, Snehal
Dubinsky, Marla
[J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S7 - S7
[50] Variability in Vedolizumab Exposure Between Patients With Inflammatory Bowel Disease
Gils, Ann
Dreesen, Erwin
Peeters, Miet
Brouwers, Els
Ferrante, Marc
Van Assche, Gert
Vermeire, Severine
[J]. GASTROENTEROLOGY, 2016, 150 (04) : S411 - S412

← 1 2 3 4 5 →